Armistice Capital, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 2,523 shares at $5.25 ($13K) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market purchase of $13k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.05 | 1,071 | $5K | 41.2% |
| 2 | $5.25 | 1,000 | $5K | 40.0% |
| 3 | $5.45 | 452 | $2K | 18.8% |
| Total | $5.20 avg | 2,523 | $13K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |